Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210,632 | 68,263 | 291,506 | 480,016 | 552,935 |
| Marketable Securities | 210 | 105,135 | 20,221 | 34,134 | 118,188 |
| Receivables | N/A | N/A | N/A | N/A | 5,191 |
| Inventories | N/A | N/A | N/A | N/A | 4,274 |
| Other current assets | 6,678 | 3,295 | 18,185 | 11,639 | 69,768 |
| TOTAL | $217,520 | $176,693 | $329,912 | $525,789 | $750,356 |
| Non-Current Assets | |||||
| PPE Net | 140 | 201 | 1,777 | 8,821 | 7,174 |
| Investments And Advances | 37,241 | 30,824 | 0 | 4,473 | 55,253 |
| Intangibles | 0 | 0 | 0 | 40,808 | 44,289 |
| Other Non-Current Assets | 5,621 | 4,962 | 37,233 | 10,734 | 21,877 |
| TOTAL | $43,002 | $35,987 | $39,010 | $64,836 | $128,593 |
| Total Assets | $260,522 | $212,680 | $368,922 | $590,625 | $878,949 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,748 | N/A |
| Accounts payable and accrued liabilities | 16,823 | 7,532 | 7,849 | 102,443 | 93,107 |
| Other current liabilities | 9,180 | 106 | N/A | 1,258 | N/A |
| TOTAL | $26,894 | $8,454 | $58,144 | $109,923 | $97,920 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 44,758 | 3,066 | 68,194 | 58,806 | 65,534 |
| TOTAL | $2,687 | $3,066 | $68,194 | $58,806 | $65,534 |
| Total Liabilities | $29,581 | $11,520 | $126,338 | $168,729 | $163,454 |
| Shareholders' Equity | |||||
| Common Shares | 27 | 19 | 19 | 19 | 20 |
| Retained earnings | -1,332,308 | -1,286,039 | -1,263,809 | -994,918 | -683,368 |
| Other shareholders' equity | 41,504 | 33,159 | 39,764 | 30,916 | -29,267 |
| TOTAL | $230,941 | $201,160 | $242,584 | $421,896 | $715,495 |
| Total Liabilities And Equity | $260,522 | $212,680 | $368,922 | $590,625 | $878,949 |